3 ml tirzepatide 149.00 | --- 27 mg / --- 3 ml vial --- Weight Loss Glucagon-Like Peptide-1 (GLP-1) Tirzepatide dosage chart in units:

Indications and Usage for Imcivree IMCIVREE is indicated to reduce excess body weight and maintain weight reduction long term in adults and pediatric patients aged [ see Dosage and Administration (2.1)]: 4 years and older with acquired hypothalamic obesity (HO) 2 years and older with syndromic or monogenic obesity due to: o Bardet-Biedl syndrome (BBS) o Pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1 (PCSK1), or leptin receptor (LEPR) deficiency confirmed by genetic testing demonstrating variants in POMC, PCSK1, or LEPR genes that are interpreted as pathogenic, likely pathogenic, or of uncertain significance (VUS)

Allison has been an unpaid member of the International Life Sciences Institute North America Board of Trustees

After reviewing your symptoms, your doctor can send an electronic prescription to your local pharmacy

ISBN 978-90-5702-597-6